COVID-19 may wreak havoc on hormones, new study suggests

NCT ID NCT05749770

Completed Knowledge-focused Sponsor: Istituto Auxologico Italiano Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at how COVID-19 infection changes hormone levels and markers of inflammation in 220 hospitalized patients. Researchers measured things like thyroid hormones, testosterone, cortisol, and vitamin D at several points during and after hospitalization. They also checked if people with pre-existing endocrine problems had worse outcomes. The goal was to understand if COVID-19 causes hormone imbalances and whether treating those imbalances could improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors understand how COVID-19 disrupts hormones and identify patients who may need extra care.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all COVID-19 patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 PANDEMIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 endocrine system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 PANDEMIC ENDOCRINE SYSTEM DISEASES

Contacts and locations

Locations

Istituto Auxologico Italiano IRCCS

Milan, 20145, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.